蛋白组学早产预测因子在大型独立前瞻性队列中的性能验证
本研究在美国18个中心的前瞻性队列中验证了胰岛素样生长因子结合蛋白4与性激素结合球蛋白比值(IGFBP4/SHBG)对极早产的预测性能。在847名孕17-21周采血的女性中,该比值对<32周早产的AUC为0.71,按BMI分层后AUC为0.76,并可预测新生儿不良结局严重程度和住院时间延长。
要点
- IGFBP4/SHBG比值可预测<32周早产,总体AUC 0.71,BMI分层后AUC 0.76。
- 该比值可预测新生儿复合患病率与死亡率评分≥3或4,AUC分别为0.67和0.78。
- 该比值可显著分层新生儿住院时间延长(log rank P=.023)。
核心结论
- 在独立队列中证实IGFBP4/SHBG比值是极早产的预测因子,并可预测新生儿住院时间延长和不良结局严重程度增加。
研究设计与样本
- 前瞻性观察性研究(NCT02787213),美国18个中心,孕17 0/7至21 6/7周采血。
- 计划分析随机选取的孕19 1/7至20 6/7周采血亚组,其余参与者结果设盲留作后续验证。
- 共入组5011名女性,847名纳入预设亚组分析,血清用质谱法分析。
主要发现
- 847名中<32 0/7周早产9例,≥32 0/7周非病例838例。
- 847名婴儿中21例新生儿复合患病与死亡指数评分≥3,其中4例评分为4。
- IGFBP4/SHBG比值在<32 0/7周早产中显著升高,且新生儿结局更严重。
- 比值预测<32 0/7周早产的AUC为0.71(95%CI 0.55-0.87,P=.016)。
- 按BMI分层(22<BMI≤37 kg/m2)后AUC为0.76(95%CI 0.59-0.93,P=.023)。
关键数值与推荐
- 预测新生儿复合患病与死亡评分≥3的AUC为0.67(95%CI 0.57-0.77,P=.005)。
- 预测新生儿复合患病与死亡评分为4的AUC为0.78(95%CI 0.63-0.93,P=.026)。
- 比值显著分层新生儿住院时间延长(log rank P=.023)。
- 新生儿复合患病与死亡指数评分0-3反映患病数量或NICU住院时间增加,4代表围产期死亡。
临床怎么用
- 该比值可用于风险分层,指导早产预防策略的实施。
- 可帮助将患者导向适当级别的 care。
局限性
- 预设亚组仅9例<32周早产,事件数少。
- 研究为观察性设计,未报告临床干预效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preterm birth remains a common and devastating complication of pregnancy. There remains a need for effective and accurate screening methods for preterm birth. Using a proteomic approach, we previously discovered and validated (Proteomic Assessment of Preterm Risk study, NCT01371019) a preterm birth predictor comprising a ratio of insulin-like growth factor-binding protein 4 to sex hormone-binding globulin. OBJECTIVE: To determine the performance of the ratio of insulin-like growth factor-binding protein 4 to sex hormone-binding globulin to predict both spontaneous and medically indicated very preterm births, in an independent cohort distinct from the one in which it was developed. STUDY DESIGN: This was a prospective observational study (Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor, NCT02787213) at 18 sites in the United States. Women had blood drawn at 170/7 to 216/7 weeks' gestation. For confirmation, we planned to analyze a randomly selected subgroup of women having blood drawn between 191/7 and 206/7 weeks' gestation, with the results of the remaining study participants blinded for future validation studies. Serum from participants was analyzed by mass spectrometry. Neonatal morbidity and mortality were analyzed using a composite score by a method from the PREGNANT trial (NCT00615550, Hassan et al). Scores of 0-3 reflect increasing numbers of morbidities or length of neonatal intensive care unit stay, and 4 represents perinatal mortality. RESULTS: A total of 5011 women were enrolled, with 847 included in this planned substudy analysis. There were 9 preterm birth cases at <320/7 weeks' gestation and 838 noncases at ≥320/7 weeks' gestation; 21 of 847 infants had neonatal composite morbidity and mortality index scores of ≥3, and 4 of 21 had a score of 4. The ratio of insulin-like growth factor-binding protein 4 to sex hormone-binding globulin ratio was substantially higher in both preterm births at <320/7 weeks' gestation and there were more severe neonatal outcomes. The ratio of insulin-like growth factor-binding protein 4 to sex hormone-binding globulin ratio was significantly predictive of birth at <320/7 weeks' gestation (area under the receiver operating characteristic curve, 0.71; 95% confidence interval, 0.55-0.87; P=.016). Stratification by body mass index, optimized in the previous validation study (22<body mass index≤37 kg/m2), resulted in an area under the receiver operating characteristic curve of 0.76 (95% confidence interval, 0.59-0.93; P=.023). The ratio of insulin-like growth factor-binding protein 4 to sex hormone-binding globulin ratio predicted neonatal outcomes with respective area under the receiver operating characteristic curve of 0.67 (95% confidence interval, 0.57-0.77; P=.005) and 0.78 (95% confidence interval, 0.63-0.93; P=.026) for neonatal composite morbidity and mortality scores of ≥3 or 4. In addition, the ratio of insulin-like growth factor-binding protein 4 to sex hormone binding globulin significantly stratified neonates with increased length of hospital stay (log rank P=.023). CONCLUSION: We confirmed in an independent cohort the ratio of insulin-like growth factor-binding protein 4 to sex hormone-binding globulin ratio as a predictor of very preterm birth, with additional prediction of increased length of neonatal hospital stay and increased severity of adverse neonatal outcomes. Potential uses of the ratio of insulin-like growth factor-binding protein 4 to sex hormone-binding globulin predictor may be to risk stratify patients for implementation of preterm birth preventive strategies and direct patients to appropriate levels of care.
引用
- Markenson GR, Saade GR, Laurent LC, et al. Performance of a proteomic preterm delivery predictor in a large independent prospective cohort. Am J Obstet Gynecol MFM. 2020. PMID: 33345877. doi:10.1016/j.ajogmf.2020.100140
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。